Meyka AI API is live for developers.Start building.
Advertisement
Grifols, S.A.

Grifols, S.A. (GRFS) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

GRFSNASDAQ
HealthcareDrug Manufacturers - General
$7.64
$0.06(0.79%)
U.S. Market opens in 45h 43m
Advertisement

Grifols, S.A. (GRFS)

Meyka AI Score

Z

Key Financials

Market Cap6.5B
P/E Ratio10.82
EPS (TTM)$0.71
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$9.53
3 Months$10.86
1 Year Target$9.97

GRFS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GRFS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.28, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.82 and a market capitalization of 6.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.79%
5-Day Change
-5.09%
1-Month Change
-7.62%
3-Month Change
-11.06%
6-Month Change
-13.67%
Year-to-Date (YTD) Change
-18.29%
1-Year Change
-12.39%
3-Year Change
-12.28%
5-Year Change
-55.37%
All-Time (Max) Change
15.41%

Contact Information

34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

23,833 Employees
IPO DateJun 2, 2011
CountryES
Actively Trading

Frequently Asked Questions